INFI Annual Total Expenses
$47.44 M
+$496.00 K+1.06%
31 December 2022
Summary:
As of January 21, 2025, INFI annual total expenses is $47.44 million, with the most recent change of +$496.00 thousand (+1.06%) on December 31, 2022. During the last 3 years, it has fallen by -$1.28 million (-2.62%).INFI Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly Total Expenses
$10.70 M
-$1.53 M-12.54%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly total expenses is $10.70 million, with the most recent change of -$1.53 million (-12.54%) on June 30, 2023. Over the past year, it has dropped by -$2.00 million (-15.75%).INFI Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.1% | -15.8% |
| 3 y3 years | -2.6% | +15.3% |
| 5 y5 years | +11.8% | +50.0% |
INFI Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -79.9% | -89.0% |
Infinity Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $10.70 M(-12.5%) |
| Mar 2023 | - | $12.24 M(+21.4%) |
| Dec 2022 | $47.44 M(+1.1%) | $10.08 M(-13.0%) |
| Sept 2022 | - | $11.59 M(-8.7%) |
| June 2022 | - | $12.70 M(-2.7%) |
| Mar 2022 | - | $13.06 M(+9.3%) |
| Dec 2021 | $46.94 M(+16.7%) | $11.95 M(+6.9%) |
| Sept 2021 | - | $11.18 M(-5.0%) |
| June 2021 | - | $11.76 M(-2.4%) |
| Mar 2021 | - | $12.05 M(+12.9%) |
| Dec 2020 | $40.22 M(-17.4%) | $10.67 M(+14.2%) |
| Sept 2020 | - | $9.34 M(+0.7%) |
| June 2020 | - | $9.28 M(-15.1%) |
| Mar 2020 | - | $10.93 M(-7.9%) |
| Dec 2019 | $48.71 M(+43.0%) | $11.86 M(+8.6%) |
| Sept 2019 | - | $10.92 M(+9.2%) |
| June 2019 | - | $10.00 M(-37.2%) |
| Mar 2019 | - | $15.93 M(+85.2%) |
| Dec 2018 | $34.08 M(-19.7%) | $8.60 M(-2.5%) |
| Sept 2018 | - | $8.82 M(+23.6%) |
| June 2018 | - | $7.13 M(-25.0%) |
| Mar 2018 | - | $9.52 M(+18.7%) |
| Dec 2017 | $42.45 M(-73.8%) | $8.02 M(-42.1%) |
| Sept 2017 | - | $13.84 M(+37.0%) |
| June 2017 | - | $10.11 M(-3.5%) |
| Mar 2017 | - | $10.48 M(-54.9%) |
| Dec 2016 | $161.83 M(-31.5%) | $23.23 M(+16.5%) |
| Sept 2016 | - | $19.93 M(-71.0%) |
| June 2016 | - | $68.64 M(+37.2%) |
| Mar 2016 | - | $50.02 M(+3.7%) |
| Dec 2015 | $236.17 M(+36.6%) | $48.24 M(+1.6%) |
| Sept 2015 | - | $47.48 M(+9.2%) |
| June 2015 | - | $43.47 M(-55.2%) |
| Mar 2015 | - | $96.98 M(+123.1%) |
| Dec 2014 | $172.92 M(+35.4%) | $43.46 M(-17.9%) |
| Sept 2014 | - | $52.94 M(+50.3%) |
| June 2014 | - | $35.22 M(-14.7%) |
| Mar 2014 | - | $41.30 M(+24.8%) |
| Dec 2013 | $127.68 M(-12.7%) | $33.08 M(-3.2%) |
| Sept 2013 | - | $34.18 M(+4.3%) |
| June 2013 | - | $32.76 M(+18.4%) |
| Mar 2013 | - | $27.66 M(-41.3%) |
| Dec 2012 | $146.28 M(+11.4%) | $47.13 M(+69.6%) |
| Sept 2012 | - | $27.79 M(-22.8%) |
| June 2012 | - | $36.01 M(+1.8%) |
| Mar 2012 | - | $35.36 M(-1.6%) |
| Dec 2011 | $131.30 M | $35.94 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $34.89 M(+11.4%) |
| June 2011 | - | $31.32 M(+7.4%) |
| Mar 2011 | - | $29.15 M(+6.1%) |
| Dec 2010 | $119.57 M(+22.9%) | $27.47 M(-37.2%) |
| Sept 2010 | - | $43.75 M(+80.6%) |
| June 2010 | - | $24.23 M(+0.4%) |
| Mar 2010 | - | $24.13 M(+13.4%) |
| Dec 2009 | $97.31 M(+51.3%) | $21.28 M(-7.8%) |
| Sept 2009 | - | $23.07 M(-12.6%) |
| June 2009 | - | $26.39 M(-0.7%) |
| Mar 2009 | - | $26.57 M(+20.6%) |
| Dec 2008 | $64.30 M(+34.4%) | $22.04 M(+42.1%) |
| Sept 2008 | - | $15.51 M(+7.3%) |
| June 2008 | - | $14.46 M(+17.6%) |
| Mar 2008 | - | $12.29 M(-15.6%) |
| Dec 2007 | $47.83 M(+5.7%) | $14.57 M(+31.7%) |
| Sept 2007 | - | $11.07 M(-3.1%) |
| June 2007 | - | $11.42 M(+6.1%) |
| Mar 2007 | - | $10.77 M(-15.0%) |
| Dec 2006 | $45.26 M(+22.3%) | $12.67 M(+18.2%) |
| Sept 2006 | - | $10.72 M(+5.0%) |
| June 2006 | - | $10.21 M(-12.4%) |
| Mar 2006 | - | $11.65 M(+12.6%) |
| Dec 2005 | $36.99 M(+9.8%) | $10.35 M(+8.0%) |
| Sept 2005 | - | $9.58 M(+265.7%) |
| June 2005 | - | $2.62 M(-76.4%) |
| Mar 2005 | - | $11.11 M(-628.5%) |
| Dec 2004 | $33.69 M(-30.8%) | -$2.10 M(-117.3%) |
| Sept 2004 | - | $12.17 M(-2.1%) |
| June 2004 | - | $12.44 M(+11.3%) |
| Mar 2004 | - | $11.18 M(-16.2%) |
| Dec 2003 | $48.70 M(-53.9%) | $13.34 M(+21.7%) |
| Sept 2003 | - | $10.97 M(-3.8%) |
| June 2003 | - | $11.39 M(-12.1%) |
| Mar 2003 | - | $12.97 M(-81.7%) |
| Dec 2002 | $105.69 M(+89.5%) | $71.04 M(+495.1%) |
| Sept 2002 | - | $11.94 M(+4.9%) |
| June 2002 | - | $11.38 M(+0.5%) |
| Mar 2002 | - | $11.33 M(-38.3%) |
| Dec 2001 | $55.78 M(+37.9%) | $18.37 M(+9.1%) |
| Sept 2001 | - | $16.84 M(+30.8%) |
| June 2001 | - | $12.87 M(+9.4%) |
| Mar 2001 | - | $11.76 M(-10.5%) |
| Dec 2000 | $40.45 M(+144.8%) | $13.13 M(+11.8%) |
| Sept 2000 | - | $11.74 M(+17.9%) |
| June 2000 | - | $9.96 M(+77.6%) |
| Mar 2000 | - | $5.61 M |
| Dec 1999 | $16.52 M | - |
FAQ
- What is Infinity Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual total expenses year-on-year change?
- What is Infinity Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly total expenses year-on-year change?
What is Infinity Pharmaceuticals annual total expenses?
The current annual total expenses of INFI is $47.44 M
What is the all time high annual total expenses for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual total expenses is $236.17 M
What is Infinity Pharmaceuticals annual total expenses year-on-year change?
Over the past year, INFI annual total expenses has changed by +$496.00 K (+1.06%)
What is Infinity Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of INFI is $10.70 M
What is the all time high quarterly total expenses for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly total expenses is $96.98 M
What is Infinity Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, INFI quarterly total expenses has changed by -$2.00 M (-15.75%)